Old Web
English
Sign In
Acemap
>
authorDetail
>
Anders Meller Donatsky
Anders Meller Donatsky
Novo Nordisk
Type 2 diabetes
Medicine
Insulin degludec
Insulin glargine
Internal medicine
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.
2021
Diabetes, Obesity and Metabolism
Anastasia-Stefania Alexopoulos
Andreas Andersen
Anders Meller Donatsky
Amoolya Gowda
John B. Buse
Show All
Source
Cite
Save
Citations (0)
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
2021
Diabetes, Obesity and Metabolism
Ronald Goldenberg
Vanita R. Aroda
Liana K. Billings
A. Sia Louise Christiansen
Anders Meller Donatsky
Ehsan Parvaresh Rizi
Gracjan Podgorski
Katarina Raslova
David C. Klonoff
Richard M. Bergenstal
Show All
Source
Cite
Save
Citations (1)
Effect of Insulin Degludec U100 vs Insulin Glargine U100 on Time in Range in Patients with Type 2 Diabetes at Risk of Hypoglycaemia
2021
Diabetologie Und Stoffwechsel
Ronald Goldenberg
Vanita R. Aroda
Liana K. Billings
Asl Christiansen
Anders Meller Donatsky
Ehsan Parvaresh Rizi
G. Podgorski
D. Westrup
K. Rašlová
David C. Klonoff
Richard M. Bergenstal
Show All
Source
Cite
Save
Citations (1)
1